Maiwald
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Sponsored
Sponsored
-
Sponsored by MaiwaldChristian Meyer of Maiwald explains several clarifications under a ruling by the German Federal Court of Justice concerning the cessation of the danger of a repeated infringement
-
Sponsored by MaiwaldBo-Hyun Lee of Maiwald considers how the Unified Patent Court will affect the successful German model of having patent attorneys and attorneys-at-law work together to handle the technical aspects of infringement proceedings
-
Sponsored by MaiwaldMarco Stief of Maiwald reports on a ruling by the CJEU that significantly extends the liability of online platforms for third-party trademark infringement and explains what it means for online marketplaces and trademark owners
-
Sponsored by MaiwaldA shift is required in the finance and banking sectors’ approach to the use of intangible capital assets as collateral, says Marco Stief of Maiwald
-
Sponsored by MaiwaldMarco Stief of Maiwald explains a ruling by the Düsseldorf Regional Court in the matter NuCana v Gilead that establishes the subsidiarity of the objection of disproportionality with regard to a compulsory licensing action
-
Sponsored by MaiwaldSusanna Heurung of Maiwald examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs